Stay updated with breaking news from Lantern Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lantern Pharma Inc. (NASDAQ:LTRN – Get Rating)’s stock price was up 8% during mid-day trading on Monday . The stock traded as high as $5.85 and last traded at $5.83. Approximately 130,592 shares were traded during mid-day trading, an increase of 304% from the average daily volume of 32,361 shares. The stock had previously closed […]
LP-184 is a novel, synthetically-lethal, small molecule that has been developed using insights from Lantern’s AI platform, RADR®. The first-in-human Phase 1A clinical trial has been... | June 12, 2023
Analysts’ new coverage for Thursday, May 18th: StockNews.com initiated coverage on shares of Agilent Technologies (NYSE:A). The firm issued a buy rating on the stock. StockNews.com assumed coverage on shares of Alcoa (NYSE:AA). They issued a sell rating on the stock. StockNews.com began coverage on shares of American Airlines Group (NASDAQ:AAL). StockNews.com issued a buy […]
Lantern Pharma Inc. , a clinical-stage biopharmaceutical company using its proprietary RADR® artificial intelligence and machine learning platform to transform the cost, pace, and timeline of... | May 17, 2023
Nicole Leber: Good afternoon, everyone. I'm Nicole Weber with Investor Relations here at Lantern Pharma. Welcome to our First Quarter 2023 Earnings Call. I will be your host for today's call.